Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04773184 · ClinicalTrials.gov registry record
Improving Diagnostic Standards in Dysphagia
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 46
- Enrollment target
NCT04773184: Completed study, sponsored by University of Florida.
NCT04773184 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04773184 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The purpose of this research is to understand the normal function of swallowing and respiratory muscles in order to establish normal parameters. This will allow us to compare normal physiology and function of swallowing and breathing muscles to people with a medical history that would put them at risk for a swallowing problem. Our goal is to identify the best tests that can be quickly and easily administered to accurately detect swallowing impairment in adults. Involvement is limited to a single 2-hour evaluation.
Primary Outcome
Validated swallowing safety measurement that is an eight-point ordinal scale to indicate the depth of airway invasion during swallowing and the associated response. A minimum score of 1 would be no airway invasion, to a maximum score of 8 being airway invasion with no effort to expel the tracheal matter. Therefore, the lower the score, the better the outcome.
Interventions
- PROCEDURE Fiberoptic Endoscopic Evaluation of Swallowing
- PROCEDURE Videofluoroscopic Swallowing Study
- PROCEDURE Voluntary Peak Cough Flow Testing
- PROCEDURE Iowa Oral Performance Instrument
- PROCEDURE Capsaicin Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2023-09-23 |
What the finished NCT04773184 record still lists
NCT04773184 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Fiberoptic Endoscopic Evaluation of Swallowing is the first listed.
NCT04773184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04773184 about?
NCT04773184 is a clinical study titled "Improving Diagnostic Standards in Dysphagia". The purpose of this research is to understand the normal function of swallowing and respiratory muscles in order to establish normal parameters. This will allow us to compare normal physiology and function of swallowing and breathing muscles to people with a medical history that would put them at ri...
What is the current status of trial NCT04773184?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2021-04-27. Estimated completion is 2023-09-23.
What interventions are being tested in trial NCT04773184?
The interventions under investigation include: Fiberoptic Endoscopic Evaluation of Swallowing (PROCEDURE), Videofluoroscopic Swallowing Study (PROCEDURE), Voluntary Peak Cough Flow Testing (PROCEDURE), Iowa Oral Performance Instrument (PROCEDURE), Capsaicin Challenge (PROCEDURE).
Who is sponsoring clinical trial NCT04773184?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI